Baird analyst Vikram Kesavabhotla initiated coverage of Hinge Health (HNGE) with a Neutral rating and $56 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health falls -8.5%
- Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating
- Hinge Health Announces Early Share Lock-Up Release
- Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald
- Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective